These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 526081)

  • 21. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
    Georgiev VP; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic inhibition of sympathetic activity in the cat.
    Dóda M; György L
    Pol J Pharmacol Pharm; 1985; 37(3):397-404. PubMed ID: 4070081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of gabaergic system on cataleptogenic action of analgesics and haloperidol.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1986; 38(5-6):501-7. PubMed ID: 3575168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA in the ventral tegmental area: differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists.
    Arnt J; Scheel-Krüger J
    Life Sci; 1979 Oct; 25(15):1351-60. PubMed ID: 574606
    [No Abstract]   [Full Text] [Related]  

  • 25. GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice.
    Shukla VK; Garg SK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):27-31. PubMed ID: 2895827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Participation of GABA and other mediators in regulating the convulsive threshold].
    Georgiev VP
    Farmakol Toksikol; 1983; 46(4):15-9. PubMed ID: 6137407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-aminobutyric acid and mefloquine-induced seizures in mice.
    Amabeoku GJ; Farmer CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):917-21. PubMed ID: 16009480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dopaminergic component in the mechanism of action of gamma-aminobutyric acid derivatives and structural analogs].
    Allikmets LKh; Polevoĭ LG; Tsareva TA; Zharkovskiĭ AM
    Farmakol Toksikol; 1979; 42(6):603-6. PubMed ID: 499466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sedative action of low doses of dopaminergic agents.
    Maj J; Przewlocka B; Kukulka L
    Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.
    Riffee WH; Wilcox RE; Goldman CP; Smith RV
    Psychopharmacology (Berl); 1981; 75(4):391-5. PubMed ID: 6803286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The threshold lowering effects of chronic treatment with haloperidol on beta-carboline derivative-induced tonic convulsion].
    Sekimoto M; Ushijima I; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1992 Jun; 12(3):121-7. PubMed ID: 1414032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gamma-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol.
    Cools AR; Janssen HJ
    J Pharm Pharmacol; 1976 Jan; 28(1):70-4. PubMed ID: 6658
    [No Abstract]   [Full Text] [Related]  

  • 36. A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats.
    Paul V; Krishnamoorthy MS
    Indian J Physiol Pharmacol; 1990 Apr; 34(2):139-42. PubMed ID: 2147669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the Mongolian gerbil.
    Löscher W
    J Pharmacol Exp Ther; 1985 Apr; 233(1):204-13. PubMed ID: 2858579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EEG analysis of the effect of stimulation of GABAergic structures of the caudate nucleus on the development of the effect of haloperidol].
    Shugalev NP; Shiriaev AD
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(1):128-34. PubMed ID: 3577401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.